MSB 1.78% $1.11 mesoblast limited

RWE for 2nd MSB COVID-19 ARDS P3 Trial, page-429

  1. 3,979 Posts.
    lightbulb Created with Sketch. 287
    I just don't get why the priority is labelled as covid ARDS. My son had covid 3 weeks ago and we would not have known except for the RAT supplied by schools. He still ate us out of the house for all food but after 7 days when finally negative he got very sick with the flu and needed to be hospitalised for breathing issues, but now negative for COVID. I do think Si has made a huge error given that ACUTE RESPIRATORY SYNDROME is associated with so many other historical illness conditions. I think he tried to play the wow factor with the Covid card, when he should have just stuck with that Rem L which assists with ARDS in general, be it COVID, flu, pneumonia or otherwise. In other words all cause ARDS as Novartis would have liked perhaps.
 
watchlist Created with Sketch. Add MSB (ASX) to my watchlist
(20min delay)
Last
$1.11
Change
-0.020(1.78%)
Mkt cap ! $1.261B
Open High Low Value Volume
$1.12 $1.13 $1.09 $4.556M 4.141M

Buyers (Bids)

No. Vol. Price($)
2 9590 $1.10
 

Sellers (Offers)

Price($) Vol. No.
$1.11 3132 1
View Market Depth
Last trade - 16.10pm 18/07/2024 (20 minute delay) ?
MSB (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.